Contemporary Issues in Lung Cancer: A Nursing PerspectiveIn the United States, lung cancer is the second most commonly diagnosed cancer and the leading cause of cancer death. Even more devastating is its five-year survival rate of only 15.8%. Despite these dismal facts, lung cancer receives little national attention and research and funding for lung cancer lags behind other cancers. The intent of Contemporary Issues in Lung Cancer: A Nursing Perspective is to provide oncology nurses and healthcare professionals with in-depth information on the issues that surround this disease, so that they might impact both education and research and provide better care for their patients. Contemporary Issues in Lung Cancer addresses all aspects of the disease from incidence, risk factors, and the biology of lung cancer, to the latest modes of treatment. Also discussed are controversies in the detection and screening of lung cancer, and the special issues facing individuals with lung cancer. |
From inside the book
Results 1-3 of 66
Page 55
Docetaxel - Based Regimens Initial combination regimens , evaluated in phase II trials , employed the use of cisplatin with various docetaxel doses administered every 21 days . Response rates ranged from 32 % to 45 % with median ...
Docetaxel - Based Regimens Initial combination regimens , evaluated in phase II trials , employed the use of cisplatin with various docetaxel doses administered every 21 days . Response rates ranged from 32 % to 45 % with median ...
Page 67
Patients with LD at the end of the third cycle were eligible to receive concurrent thoracic radiation with the fourth cycle of chemotherapy ( Dose 35 Gy ) . Patients with LD who achieved a complete response received prophylactic cranial ...
Patients with LD at the end of the third cycle were eligible to receive concurrent thoracic radiation with the fourth cycle of chemotherapy ( Dose 35 Gy ) . Patients with LD who achieved a complete response received prophylactic cranial ...
Page 248
To date , there is no optimal dosage or length of treatment for the patch . Treatment is initiated on the quit day with a dose of 15 or 21 mg . Heavier smokers usually receive treatment with 21 mg whereas those who are light to moderate ...
To date , there is no optimal dosage or length of treatment for the patch . Treatment is initiated on the quit day with a dose of 15 or 21 mg . Heavier smokers usually receive treatment with 21 mg whereas those who are light to moderate ...
What people are saying - Write a review
We haven't found any reviews in the usual places.
Contents
SEPARATING OUT THE DIFFERENCES BETWEEN LUNG | 3 |
BIOLOGY OF LUNG CANCER | 11 |
CONTROVERSIES IN DETECTION AND SCREENING | 24 |
Copyright | |
19 other sections not shown
Other editions - View all
Common terms and phrases
activity addition agents American approach assessment associated behavior cancer patients carcinoma cause cell lung cancer chemotherapy chest cisplatin Clinical Clinical Oncology combination communication continued decreased depression determine diagnosis discussion disease dose drug dyspnea early effects et al evaluated evidence experience factors fatigue foods function hope identified impact important improve increased individuals initial intervention issues Journal less levels loss measures Medicine months non-small cell lung NSCLC Nursing nutritional occur Oncology Oncology Nursing paclitaxel pain persons phase physical physician potential practice present problems radiation radiotherapy radon randomized rates receiving regimens reported resection response risk role SCLC sleep smoking Society specific Stage surgery symptoms Table testing therapy thoracic thoracotomy tion treated treatment trials tumor weeks weight
Bibliographic information
| Title | Contemporary Issues in Lung Cancer: A Nursing Perspective Jones and Bartlett series in oncology, ISSN 1535-9999 |
| Editor | Marilyn Haas |
| Edition | illustrated |
| Publisher | Jones and Bartlett Publishers, 2003 |
| Original from | the University of Michigan |
| Digitized | 2 Aug 2008 |
| ISBN | 0763719145, 9780763719142 |
| Length | 322 pages |
| Export Citation | BiBTeX EndNote RefMan |